These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23341381)

  • 1. Application of real-time ultrasound elastography for discrimination of low- and high-grade serous ovarian carcinoma.
    Xie M; Zhang X; Zhan J; Hua K
    J Ultrasound Med; 2013 Feb; 32(2):257-62. PubMed ID: 23341381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging in gynecological disease (12): clinical and ultrasound features of invasive and non-invasive malignant serous ovarian tumors.
    Moro F; Baima Poma C; Zannoni GF; Vidal Urbinati A; Pasciuto T; Ludovisi M; Moruzzi MC; Carinelli S; Franchi D; Scambia G; Testa AC
    Ultrasound Obstet Gynecol; 2017 Dec; 50(6):788-799. PubMed ID: 28101917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elastography, a sensitive tool for the evaluation of neoadjuvant chemotherapy in patients with high-grade serous ovarian carcinoma.
    Xie M; Zhang X; Jia Z; Ren Y; Wang W
    Oncol Lett; 2014 Oct; 8(4):1652-1656. PubMed ID: 25202385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extrauterine Pelvic Serous Carcinomas: Current Update on Pathology and Cross-sectional Imaging Findings.
    Katabathina VS; Amanullah FS; Menias CO; Chen MM; Valente PT; Chintapalli KN; Prasad SR
    Radiographics; 2016; 36(3):918-32. PubMed ID: 27163599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study.
    Petrillo M; Marchetti C; De Leo R; Musella A; Capoluongo E; Paris I; Benedetti Panici P; Scambia G; Fagotti A
    Am J Obstet Gynecol; 2017 Sep; 217(3):334.e1-334.e9. PubMed ID: 28549976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian low-grade serous carcinoma involving the cervix mimicking a cervical primary.
    Malpica A; Deavers MT
    Int J Gynecol Pathol; 2011 Nov; 30(6):613-9. PubMed ID: 21979600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic Markers and Statistical Prediction of Serous Ovarian Cancer Aggressiveness by Ambient Ionization Mass Spectrometry Imaging.
    Sans M; Gharpure K; Tibshirani R; Zhang J; Liang L; Liu J; Young JH; Dood RL; Sood AK; Eberlin LS
    Cancer Res; 2017 Jun; 77(11):2903-2913. PubMed ID: 28416487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-grade ovarian serous neoplasms (low-grade serous carcinoma and serous borderline tumor) associated with high-grade serous carcinoma or undifferentiated carcinoma: report of a series of cases of an unusual phenomenon.
    Boyd C; McCluggage WG
    Am J Surg Pathol; 2012 Mar; 36(3):368-75. PubMed ID: 22082603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A modified diffusion-weighted magnetic resonance imaging-based model from the radiologist's perspective: improved performance in determining the surgical resectability of advanced high-grade serous ovarian cancer.
    Lu J; Guo Q; Zhang Y; Zhao S; Li R; Fu Y; Feng Z; Wu Y; Li R; Li X; Qiang J; Wu X; Gu Y; Li H
    Am J Obstet Gynecol; 2024 Jul; 231(1):117.e1-117.e17. PubMed ID: 38432417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinicopathologic study and immunohistochemistry comparison of Pax2, p53 and Ki-67 in low- and high-grade ovarian serous carcinomas].
    Shen XX; Yu L; Bi R; Yang WT
    Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):511-6. PubMed ID: 22169637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preliminary study on the relationship between tubal intraepithelial carcinoma of the fimbria and pelvic high-grade serous carcinoma].
    Liang Y; Chen XD; Lü BJ; Zhou CY; Zhang XF; Shi HY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):724-8. PubMed ID: 22321343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant transformation of a serous borderline tumor and early metastasis of associated low-grade serous carcinoma detected on screening mammography.
    Rohsbach D; Trillsch F; Regier M; Choschzick M; Kommoss F; Hermsteiner M; Töllner T; Mattner UM; Jaenicke F; Mahner S
    J Clin Oncol; 2011 Oct; 29(30):e763-5. PubMed ID: 21931030
    [No Abstract]   [Full Text] [Related]  

  • 13. Should All Cases of High-Grade Serous Ovarian, Tubal, and Primary Peritoneal Carcinomas Be Reclassified as Tubo-Ovarian Serous Carcinoma?
    Moss EL; Evans T; Pearmain P; Askew S; Singh K; Chan KK; Ganesan R; Hirschowitz L
    Int J Gynecol Cancer; 2015 Sep; 25(7):1201-7. PubMed ID: 26035124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct preoperative clinical features predict four histopathological subtypes of high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum.
    Ohsuga T; Yamaguchi K; Kido A; Murakami R; Abiko K; Hamanishi J; Kondoh E; Baba T; Konishi I; Matsumura N
    BMC Cancer; 2017 Aug; 17(1):580. PubMed ID: 28851311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are all pelvic (nonuterine) serous carcinomas of tubal origin?
    Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R
    Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasound elastography in the differential diagnosis of benign and malignant cervical lesions.
    Lu R; Xiao Y; Liu M; Shi D
    J Ultrasound Med; 2014 Apr; 33(4):667-71. PubMed ID: 24658946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.
    McCluggage WG
    Pathology; 2011 Aug; 43(5):420-32. PubMed ID: 21716157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of low-grade serous ovarian cancer with calcified metastases: Integrating tumor markers and multimodal imaging.
    Zhang T; Tan H
    Asian J Surg; 2024 Oct; 47(10):4349-4350. PubMed ID: 38937234
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinically occult tubal and ovarian high-grade serous carcinomas presenting in uterine samples: diagnostic pitfalls and clues to improve recognition of tumor origin.
    Bagby C; Ronnett BM; Yemelyanova A; Maleki Z; Kuhn E; Vang R
    Int J Gynecol Pathol; 2013 Sep; 32(5):433-43. PubMed ID: 23896706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian serous cystadenofibromas associated with a low-grade serous carcinoma of the peritoneum.
    Hinson SA; Silva EG; Pinto K
    Ann Diagn Pathol; 2013 Jun; 17(3):302-4. PubMed ID: 22921726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.